Abstract | OBJECTIVES: METHODS: A Waters Acquity UPLC HSS C18 column was used with 0.1% formic acid in water/ acetonitrile as mobile phases. Analysis was performed in a positive ionization mode with multiple-reactions monitoring scan type. Five percent trichloroacetic acid was used to precipitate proteins in biological samples and to increase the sensitivity of detection. RESULTS: Our results showed a linear concentration range of 0.0065-3.2 mg/L for all the major polymyxin B components in both serum and ELF, respectively; the interday variation was <10% and the accuracy was 88%-115%. The validated method was used to characterize the pharmacokinetics (serum and ELF) of polymyxin B in mice. CONCLUSIONS: This is the first report, to date, examining the individual pharmacokinetics of various polymyxin B components in mice. Our results revealed no considerable differences in clearances among the components. The limited exposure of polymyxin B in ELF observed was consistent with the less favourable efficacy of polymyxin B reported for the treatment of pulmonary infections. This method can be used to further examine the pharmacokinetics of polymyxin B in a variety of clinical and experimental settings.
|
Authors | Jie He, Song Gao, Ming Hu, Diana S-L Chow, Vincent H Tam |
Journal | The Journal of antimicrobial chemotherapy
(J Antimicrob Chemother)
Vol. 68
Issue 5
Pg. 1104-10
(May 2013)
ISSN: 1460-2091 [Electronic] England |
PMID | 23341128
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Validation Study)
|
Chemical References |
- Anti-Bacterial Agents
- Polymyxin B
|
Topics |
- Animals
- Anti-Bacterial Agents
(analysis, pharmacokinetics)
- Body Fluids
(chemistry)
- Chromatography, Liquid
(methods)
- Female
- Mice
- Polymyxin B
(analysis, pharmacokinetics)
- Reproducibility of Results
- Tandem Mass Spectrometry
(methods)
|